NCT01225965

Efficacy and Feasibility of Ectoin® Inhalation Solution in Inflammatory Obstruction and Ageing of the Lung

An Efficacy and Feasibility Study to Investigate the Effect of Ectoin® Inhalation Solution (EIL) in Subjects With Inflammation and Airway Obstruction Followed by a Long Term Study Extension on the Prevention of Lung Function Decline

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 36 (actual)
• Sponsor: Bitop AG · Industry
• Sex: Female
• Age: 75 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

To investigate the physical inflammation inhibition effects of EIL (Ectoin-Hydro-Complex) in subjects of the established SALIA-cohort and the preventive effects on lung function decline.

Conditions

• COPD
• Particulate Matter Induced Inflammation of the Lung

Interventions

Type	Name	Description
DEVICE	Ectoin Inhalation Solution	Once daily inhalation of Ectoin Inhalation Solution
DEVICE	Placebo	Once daily inhalation of Placebo Inhalation Solution

Timeline

• Start date: 2010-10-01
• Primary completion: 2011-02-01
• Completion: 2011-09-01
• First posted: 2010-10-21
• Last updated: 2026-01-29

Locations

1 site across 1 country: Germany